Antipsychotic medications and cardiac conduction risks

Issues in Mental Health Nursing

Volumn 31, Issue 1, 2010, Pages 68-70

  Roman, Marian ^a   Farmer, Shirley Y ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; THIORIDAZINE;

ARTICLE; CHEMICALLY INDUCED DISORDER; COMORBIDITY; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; LONG QT SYNDROME; NURSING; NURSING ASSESSMENT; PSYCHOSIS; RISK FACTOR; SUDDEN DEATH; TORSADE DES POINTES;

ANTIPSYCHOTIC AGENTS; COMORBIDITY; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HUMANS; LONG QT SYNDROME; NURSING ASSESSMENT; PSYCHOTIC DISORDERS; RISK FACTORS; THIORIDAZINE; TORSADES DE POINTES;

EID: 71449126474     PISSN: 01612840     EISSN: 10964673     Source Type: Journal    
DOI: 10.3109/01612840903398735     Document Type: Article

References (10)

1. Al-Khatib, S. M., LaPointe, N. M., Kramer, J. M., & Califf, R. M. ( 2003). What clinicians should know about the QT interval. Journal of the American Medical Association, 289, 2120-2127.
2. American Psychiatric Association. (1999). Practice guidelines for the treatment of delirium. American Journal of Psychiatry, 156, 5(Suppl), S1-S20.
3. Glassman, A. H., & Bigger, T. J. (2001). Antipsychotic drugs: Prolonged QTc interval, torsades de pointes, and sudden death. American Journal of Psychiatry, 158, 1774-1782.
4. Guyton, A. C. (1991). Textbook of medical physiology (8th ed.). Philadelphia: Saunders.
5. Ray, W. A., Meredith, S., & Thapa, P. B. (2001). Antipsychotics and the risk of sudden cardiac death. Archives of General Psychiatry, 58, 1161-1167.
6. Sala, M., Lazzaretti, M., De Vidovich, G., Caverzasi, E., Barale, F., d'Allio, G., et al. (2009). Electrophysiological changes of cardiac function during antidepressant treatment. Therapeutic Advances in Cardiovascular Disease, 3(1), 29-43.
7. Sicouri, S., & Antzelevitch, C. (2008). Sudden cardiac death secondary to antidepressants and antipsychotic drugs. Expert Opinion Drug Safety, 7, 181-194.
8. Stahl, S. M. (2008). Essential psychopharmacology: The prescriber's guide. New York: Cambridge. Available at http://stahlonline.cambridge.org/ prescribers drug.jsf?page=0521683505c97 P549-554.html.dosing&name= Ziprasidone&titleDosing. Accessed on October 13, 2009.
9. Taylor, D. M. (2003). Antipsychotics and QT prolongation. Acta Psychiatrica Scandinavica, 107, 85-95.
10. Vieweg, V. W. (2003). New generation antipsychotic drugs and QTc interval prolongation. Primary Care Companion Journal of Clinical Psychiatry, 5, 205-215.